High-Level Serum Antibodies to Bacterial Antigens Are Associated with Antibiotic-Induced Clinical Remission in Crohn's Disease: A Pilot Study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-08

AUTHORS

William S. Mow, Carol J. Landers, A. Hillary Steinhart, Brian G. Feagan, Ken Croitoru, Ernest Seidman, Gordon R. Greenberg, Stephan R. Targan

ABSTRACT

In Crohn's disease, antibiotics are used with variable efficacy, suggesting that some patients are more likely to respond. The aim of this study was to determine whether Crohn's patients with predominant serum antibody reactivity toward bacterial antigens OmpC and/or I2 were more likely to achieve remission with antibiotics. Patients with ileal or ileal with right-sided colonic Crohn's disease were studied in a double-blind trial of budesonide alone or budesonide plus metronidazole and ciprofloxacin. In the budesonide plus metronidazole and ciprofloxacin group, patients with OmpC/I2 predominant profiles had the highest remission rate, whereas the group with no antibody predominant profiles had the lowest rate. In the budesonide group, patients with the OmpC/I2 predominant profile had the lowest remission rate, and the no-antibody group rate was higher. Although not statistically significant, these results support further testing to determine whether predominant serum reactivity to certain bacterial antigens may be a marker for efficacious use of antibiotics. More... »

PAGES

1280-1286

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/b:ddas.0000037824.66186.e2

DOI

http://dx.doi.org/10.1023/b:ddas.0000037824.66186.e2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023804442

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15387358


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Infective Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Antineutrophil Cytoplasmic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Budesonide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ciprofloxacin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Crohn Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metronidazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Porins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pseudomonas fluorescens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Superantigens", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars\u2013Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars\u2013Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mow", 
        "givenName": "William S.", 
        "id": "sg:person.01132577576.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132577576.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars\u2013Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars\u2013Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Landers", 
        "givenName": "Carol J.", 
        "id": "sg:person.01352161553.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352161553.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Division of Gastroenterology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Steinhart", 
        "givenName": "A. Hillary", 
        "id": "sg:person.016163247733.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016163247733.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Robarts Clinical Trials Research Group, The John P. Robarts Research Institute, London, Ontario", 
          "id": "http://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Robarts Clinical Trials Research Group, The John P. Robarts Research Institute, London, Ontario"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feagan", 
        "givenName": "Brian G.", 
        "id": "sg:person.013416477505.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013416477505.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Robarts Clinical Trials Research Group, The John P. Robarts Research Institute, London, Ontario", 
          "id": "http://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Robarts Clinical Trials Research Group, The John P. Robarts Research Institute, London, Ontario"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Croitoru", 
        "givenName": "Ken", 
        "id": "sg:person.013426062514.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013426062514.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gastroenterology Division, St. Justine Hospital, Montreal, Quebec, Canada", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Gastroenterology Division, St. Justine Hospital, Montreal, Quebec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seidman", 
        "givenName": "Ernest", 
        "id": "sg:person.0702704643.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702704643.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Division of Gastroenterology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Greenberg", 
        "givenName": "Gordon R.", 
        "id": "sg:person.012442562657.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012442562657.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars\u2013Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars\u2013Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Targan", 
        "givenName": "Stephan R.", 
        "id": "sg:person.01074661215.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074661215.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1111/j.1572-0241.2001.03613.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025593726", 
          "https://doi.org/10.1111/j.1572-0241.2001.03613.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35079107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031360950", 
          "https://doi.org/10.1038/35079107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35079114", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030806509", 
          "https://doi.org/10.1038/35079114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1005588911207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033842020", 
          "https://doi.org/10.1023/a:1005588911207"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-08", 
    "datePublishedReg": "2004-08-01", 
    "description": "In Crohn's disease, antibiotics are used with variable efficacy, suggesting that some patients are more likely to respond. The aim of this study was to determine whether Crohn's patients with predominant serum antibody reactivity toward bacterial antigens OmpC and/or I2 were more likely to achieve remission with antibiotics. Patients with ileal or ileal with right-sided colonic Crohn's disease were studied in a double-blind trial of budesonide alone or budesonide plus metronidazole and ciprofloxacin. In the budesonide plus metronidazole and ciprofloxacin group, patients with OmpC/I2 predominant profiles had the highest remission rate, whereas the group with no antibody predominant profiles had the lowest rate. In the budesonide group, patients with the OmpC/I2 predominant profile had the lowest remission rate, and the no-antibody group rate was higher. Although not statistically significant, these results support further testing to determine whether predominant serum reactivity to certain bacterial antigens may be a marker for efficacious use of antibiotics.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/b:ddas.0000037824.66186.e2", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2436126", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2683133", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1018525", 
        "issn": [
          "0163-2116", 
          "1573-2568"
        ], 
        "name": "Digestive Diseases and Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7-8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "49"
      }
    ], 
    "keywords": [
      "Crohn's disease", 
      "remission rate", 
      "bacterial antigens", 
      "predominant profile", 
      "double-blind trial", 
      "colonic Crohn's disease", 
      "higher remission rates", 
      "lower remission rate", 
      "serum antibody reactivity", 
      "budesonide group", 
      "certain bacterial antigens", 
      "clinical remission", 
      "ciprofloxacin group", 
      "Crohn's patients", 
      "serum reactivity", 
      "serum antibodies", 
      "patients", 
      "antibody reactivity", 
      "variable efficacy", 
      "budesonide", 
      "disease", 
      "efficacious use", 
      "pilot study", 
      "remission", 
      "group rate", 
      "antibiotics", 
      "lower rates", 
      "metronidazole", 
      "antigen", 
      "further testing", 
      "group", 
      "ileal", 
      "trials", 
      "antibodies", 
      "efficacy", 
      "rate", 
      "ciprofloxacin", 
      "markers", 
      "study", 
      "profile", 
      "aim", 
      "reactivity", 
      "testing", 
      "use", 
      "I2", 
      "results", 
      "OmpC"
    ], 
    "name": "High-Level Serum Antibodies to Bacterial Antigens Are Associated with Antibiotic-Induced Clinical Remission in Crohn's Disease: A Pilot Study", 
    "pagination": "1280-1286", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023804442"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/b:ddas.0000037824.66186.e2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15387358"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/b:ddas.0000037824.66186.e2", 
      "https://app.dimensions.ai/details/publication/pub.1023804442"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_392.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/b:ddas.0000037824.66186.e2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/b:ddas.0000037824.66186.e2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/b:ddas.0000037824.66186.e2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/b:ddas.0000037824.66186.e2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/b:ddas.0000037824.66186.e2'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      91 URIs      79 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/b:ddas.0000037824.66186.e2 schema:about N07dc245810f34c559e9670e4105bb4f6
2 N0be32fd69936469093faec42113397ba
3 N240bf2e950cb46acb7ef4ed15c0f2a45
4 N61f4c466d5fb4287b9bd3a453c90e048
5 N70bfced63a2843c99862c62cd06ab17b
6 N740e51bf4b8f4c25a827d97572f35b1f
7 N75bd19f1be484c048731240b27b0f222
8 N85582de6d0054d308bcba703a9cf071d
9 N97738ee9ad4b473fa1c10167325f2cb4
10 N9bf251c7ea6f4a7a91b8b554eb88db9b
11 Na0aaef779010456a969c616f21d7929e
12 Nab472cb00bb346dfb48eb1abb74c2750
13 Ne0828725bd374a4f9dde31f2ce2752f8
14 Nf9b02e8aa381403f91b59199f0ed5349
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N770339a9382540759bb95819091b026c
18 schema:citation sg:pub.10.1023/a:1005588911207
19 sg:pub.10.1038/35079107
20 sg:pub.10.1038/35079114
21 sg:pub.10.1111/j.1572-0241.2001.03613.x
22 schema:datePublished 2004-08
23 schema:datePublishedReg 2004-08-01
24 schema:description In Crohn's disease, antibiotics are used with variable efficacy, suggesting that some patients are more likely to respond. The aim of this study was to determine whether Crohn's patients with predominant serum antibody reactivity toward bacterial antigens OmpC and/or I2 were more likely to achieve remission with antibiotics. Patients with ileal or ileal with right-sided colonic Crohn's disease were studied in a double-blind trial of budesonide alone or budesonide plus metronidazole and ciprofloxacin. In the budesonide plus metronidazole and ciprofloxacin group, patients with OmpC/I2 predominant profiles had the highest remission rate, whereas the group with no antibody predominant profiles had the lowest rate. In the budesonide group, patients with the OmpC/I2 predominant profile had the lowest remission rate, and the no-antibody group rate was higher. Although not statistically significant, these results support further testing to determine whether predominant serum reactivity to certain bacterial antigens may be a marker for efficacious use of antibiotics.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf Ncc33121d3ada46c5a59fd6dcf2b4a479
28 Nd219c2d689b943d6ab42491f20ae1801
29 sg:journal.1018525
30 schema:keywords Crohn's disease
31 Crohn's patients
32 I2
33 OmpC
34 aim
35 antibiotics
36 antibodies
37 antibody reactivity
38 antigen
39 bacterial antigens
40 budesonide
41 budesonide group
42 certain bacterial antigens
43 ciprofloxacin
44 ciprofloxacin group
45 clinical remission
46 colonic Crohn's disease
47 disease
48 double-blind trial
49 efficacious use
50 efficacy
51 further testing
52 group
53 group rate
54 higher remission rates
55 ileal
56 lower rates
57 lower remission rate
58 markers
59 metronidazole
60 patients
61 pilot study
62 predominant profile
63 profile
64 rate
65 reactivity
66 remission
67 remission rate
68 results
69 serum antibodies
70 serum antibody reactivity
71 serum reactivity
72 study
73 testing
74 trials
75 use
76 variable efficacy
77 schema:name High-Level Serum Antibodies to Bacterial Antigens Are Associated with Antibiotic-Induced Clinical Remission in Crohn's Disease: A Pilot Study
78 schema:pagination 1280-1286
79 schema:productId N166985de92b94f2f9f94770277186efb
80 N424448fc1e17413da5d4dadfe540e892
81 Nc90af81dcd50411d81b716862f35192b
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023804442
83 https://doi.org/10.1023/b:ddas.0000037824.66186.e2
84 schema:sdDatePublished 2022-09-02T15:50
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher Ne855b6c5522b4724814f96b3f7485c6d
87 schema:url https://doi.org/10.1023/b:ddas.0000037824.66186.e2
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N039e1a01517646e493ba00e3bd092d4a rdf:first sg:person.013416477505.85
92 rdf:rest N748de4fcd2a84fb280920fe159dc526a
93 N07dc245810f34c559e9670e4105bb4f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Drug Therapy, Combination
95 rdf:type schema:DefinedTerm
96 N0be32fd69936469093faec42113397ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Humans
98 rdf:type schema:DefinedTerm
99 N166985de92b94f2f9f94770277186efb schema:name doi
100 schema:value 10.1023/b:ddas.0000037824.66186.e2
101 rdf:type schema:PropertyValue
102 N1f187815c9c94a139230c217fafbbdff rdf:first sg:person.01074661215.00
103 rdf:rest rdf:nil
104 N240bf2e950cb46acb7ef4ed15c0f2a45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Metronidazole
106 rdf:type schema:DefinedTerm
107 N424448fc1e17413da5d4dadfe540e892 schema:name dimensions_id
108 schema:value pub.1023804442
109 rdf:type schema:PropertyValue
110 N61f4c466d5fb4287b9bd3a453c90e048 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Antigens, Bacterial
112 rdf:type schema:DefinedTerm
113 N626cee7feff9463da9afc04311f165c6 rdf:first sg:person.012442562657.07
114 rdf:rest N1f187815c9c94a139230c217fafbbdff
115 N70bfced63a2843c99862c62cd06ab17b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Antibodies, Antineutrophil Cytoplasmic
117 rdf:type schema:DefinedTerm
118 N740e51bf4b8f4c25a827d97572f35b1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Remission Induction
120 rdf:type schema:DefinedTerm
121 N748de4fcd2a84fb280920fe159dc526a rdf:first sg:person.013426062514.54
122 rdf:rest Nbc71c79e206043d0b4948ea8e2c599c3
123 N75bd19f1be484c048731240b27b0f222 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Ciprofloxacin
125 rdf:type schema:DefinedTerm
126 N770339a9382540759bb95819091b026c rdf:first sg:person.01132577576.07
127 rdf:rest Ncaf50ffdf82d43149a9508281a707c42
128 N85582de6d0054d308bcba703a9cf071d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Crohn Disease
130 rdf:type schema:DefinedTerm
131 N97738ee9ad4b473fa1c10167325f2cb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Anti-Infective Agents
133 rdf:type schema:DefinedTerm
134 N9bf251c7ea6f4a7a91b8b554eb88db9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Porins
136 rdf:type schema:DefinedTerm
137 Na0aaef779010456a969c616f21d7929e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Pilot Projects
139 rdf:type schema:DefinedTerm
140 Na96e6ec14a6a4f33a57e34f11e267bf4 rdf:first sg:person.016163247733.40
141 rdf:rest N039e1a01517646e493ba00e3bd092d4a
142 Nab472cb00bb346dfb48eb1abb74c2750 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Superantigens
144 rdf:type schema:DefinedTerm
145 Nbc71c79e206043d0b4948ea8e2c599c3 rdf:first sg:person.0702704643.96
146 rdf:rest N626cee7feff9463da9afc04311f165c6
147 Nc90af81dcd50411d81b716862f35192b schema:name pubmed_id
148 schema:value 15387358
149 rdf:type schema:PropertyValue
150 Ncaf50ffdf82d43149a9508281a707c42 rdf:first sg:person.01352161553.31
151 rdf:rest Na96e6ec14a6a4f33a57e34f11e267bf4
152 Ncc33121d3ada46c5a59fd6dcf2b4a479 schema:volumeNumber 49
153 rdf:type schema:PublicationVolume
154 Nd219c2d689b943d6ab42491f20ae1801 schema:issueNumber 7-8
155 rdf:type schema:PublicationIssue
156 Ne0828725bd374a4f9dde31f2ce2752f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Pseudomonas fluorescens
158 rdf:type schema:DefinedTerm
159 Ne855b6c5522b4724814f96b3f7485c6d schema:name Springer Nature - SN SciGraph project
160 rdf:type schema:Organization
161 Nf9b02e8aa381403f91b59199f0ed5349 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Budesonide
163 rdf:type schema:DefinedTerm
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
168 schema:name Clinical Sciences
169 rdf:type schema:DefinedTerm
170 sg:grant.2436126 http://pending.schema.org/fundedItem sg:pub.10.1023/b:ddas.0000037824.66186.e2
171 rdf:type schema:MonetaryGrant
172 sg:grant.2683133 http://pending.schema.org/fundedItem sg:pub.10.1023/b:ddas.0000037824.66186.e2
173 rdf:type schema:MonetaryGrant
174 sg:journal.1018525 schema:issn 0163-2116
175 1573-2568
176 schema:name Digestive Diseases and Sciences
177 schema:publisher Springer Nature
178 rdf:type schema:Periodical
179 sg:person.01074661215.00 schema:affiliation grid-institutes:grid.19006.3e
180 schema:familyName Targan
181 schema:givenName Stephan R.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074661215.00
183 rdf:type schema:Person
184 sg:person.01132577576.07 schema:affiliation grid-institutes:grid.19006.3e
185 schema:familyName Mow
186 schema:givenName William S.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132577576.07
188 rdf:type schema:Person
189 sg:person.012442562657.07 schema:affiliation grid-institutes:grid.17063.33
190 schema:familyName Greenberg
191 schema:givenName Gordon R.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012442562657.07
193 rdf:type schema:Person
194 sg:person.013416477505.85 schema:affiliation grid-institutes:grid.39381.30
195 schema:familyName Feagan
196 schema:givenName Brian G.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013416477505.85
198 rdf:type schema:Person
199 sg:person.013426062514.54 schema:affiliation grid-institutes:grid.39381.30
200 schema:familyName Croitoru
201 schema:givenName Ken
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013426062514.54
203 rdf:type schema:Person
204 sg:person.01352161553.31 schema:affiliation grid-institutes:grid.19006.3e
205 schema:familyName Landers
206 schema:givenName Carol J.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352161553.31
208 rdf:type schema:Person
209 sg:person.016163247733.40 schema:affiliation grid-institutes:grid.17063.33
210 schema:familyName Steinhart
211 schema:givenName A. Hillary
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016163247733.40
213 rdf:type schema:Person
214 sg:person.0702704643.96 schema:affiliation grid-institutes:None
215 schema:familyName Seidman
216 schema:givenName Ernest
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702704643.96
218 rdf:type schema:Person
219 sg:pub.10.1023/a:1005588911207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033842020
220 https://doi.org/10.1023/a:1005588911207
221 rdf:type schema:CreativeWork
222 sg:pub.10.1038/35079107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031360950
223 https://doi.org/10.1038/35079107
224 rdf:type schema:CreativeWork
225 sg:pub.10.1038/35079114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030806509
226 https://doi.org/10.1038/35079114
227 rdf:type schema:CreativeWork
228 sg:pub.10.1111/j.1572-0241.2001.03613.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025593726
229 https://doi.org/10.1111/j.1572-0241.2001.03613.x
230 rdf:type schema:CreativeWork
231 grid-institutes:None schema:alternateName Gastroenterology Division, St. Justine Hospital, Montreal, Quebec, Canada
232 schema:name Gastroenterology Division, St. Justine Hospital, Montreal, Quebec, Canada
233 rdf:type schema:Organization
234 grid-institutes:grid.17063.33 schema:alternateName Division of Gastroenterology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario
235 schema:name Division of Gastroenterology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario
236 rdf:type schema:Organization
237 grid-institutes:grid.19006.3e schema:alternateName Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars–Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA
238 schema:name Inflammatory Bowel Disease Center, Division of Gastroenterology, Cedars–Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA
239 rdf:type schema:Organization
240 grid-institutes:grid.39381.30 schema:alternateName Robarts Clinical Trials Research Group, The John P. Robarts Research Institute, London, Ontario
241 schema:name Robarts Clinical Trials Research Group, The John P. Robarts Research Institute, London, Ontario
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...